These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 7690449

  • 21. Inhibition of 3H-leukotriene D4 binding to guinea pig lung receptors by the novel leukotriene antagonist ICI 198,615.
    Aharony D, Falcone RC, Krell RD.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):921-6. PubMed ID: 2826761
    [Abstract] [Full Text] [Related]

  • 22. Pharmacological characterization of cloned human NK-2 (neurokinin A) receptor expressed in a baculovirus/Sf-21 insect cell system.
    Aharony D, Little J, Powell S, Hopkins B, Bundell KR, McPheat WL, Gordon RD, Hassall G, Hockney R, Griffin R.
    Mol Pharmacol; 1993 Aug; 44(2):356-63. PubMed ID: 8394992
    [Abstract] [Full Text] [Related]

  • 23. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
    Catalioto RM, Criscuoli M, Cucchi P, Giachetti A, Gianotti D, Giuliani S, Lecci A, Lippi A, Patacchini R, Quartara L, Renzetti AR, Tramontana M, Arcamone F, Maggi CA.
    Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
    [Abstract] [Full Text] [Related]

  • 24. Pharmacologic characterization of the novel ligand [4,5-3H-Leu9]neurokinin-A binding to NK-2 receptors on hamster urinary bladder membranes.
    Aharony D, Conner GE, Woodhouse DP.
    Neuropeptides; 1992 Oct; 23(2):121-30. PubMed ID: 1333574
    [Abstract] [Full Text] [Related]

  • 25. A novel irreversible antagonist of the A1-adenosine receptor.
    Srinivas M, Shryock JC, Scammells PJ, Ruble J, Baker SP, Belardinelli L.
    Mol Pharmacol; 1996 Jul; 50(1):196-205. PubMed ID: 8700113
    [Abstract] [Full Text] [Related]

  • 26. Differential activation of the epithelial and smooth muscle NK1 receptors by synthetic tachykinin agonists in guinea-pig trachea.
    Figini M, Emanueli C, Bertrand C, Sicuteri R, Regoli D, Geppetti P.
    Br J Pharmacol; 1997 Jun; 121(4):773-81. PubMed ID: 9208147
    [Abstract] [Full Text] [Related]

  • 27. Autoradiographic localization of tachykinin NK2 and NK1 receptors in the guinea-pig lung, using selective radioligands.
    Strigas J, Burcher E.
    Eur J Pharmacol; 1996 Sep 12; 311(2-3):177-86. PubMed ID: 8891598
    [Abstract] [Full Text] [Related]

  • 28. Characterization of NK-1 receptors in guinea pig and rat brain membranes with NK-1 peptides and a non-peptide antagonist.
    Tousignant C, Chrétien L, Guillemette G, Regoli D.
    Brain Res; 1992 Nov 20; 596(1-2):243-50. PubMed ID: 1281744
    [Abstract] [Full Text] [Related]

  • 29. Autoradiographic mapping of pulmonary NK1 and NK2 tachykinin receptors and changes after repeated antigen challenge in guinea pigs.
    Mak JC, Astolfi M, Zhang XL, Evangelista S, Manzini S, Barnes PJ.
    Peptides; 1996 Nov 20; 17(8):1389-95. PubMed ID: 8971936
    [Abstract] [Full Text] [Related]

  • 30. Pharmacological characterization of a new class of nonpeptide neurokinin A antagonists that demonstrate species selectivity.
    Aharony D, Buckner CK, Ellis JL, Ghanekar SV, Graham A, Kays JS, Little J, Meeker S, Miller SC, Undem BJ.
    J Pharmacol Exp Ther; 1995 Sep 20; 274(3):1216-21. PubMed ID: 7562491
    [Abstract] [Full Text] [Related]

  • 31. 3H-neurokinin A labels a specific tachykinin-binding site in the rat duodenal smooth muscle.
    Bergström L, Beaujouan JC, Torrens Y, Saffroy M, Glowinski J, Lavielle S, Chassaing G, Marquet A, D'Orleans-Juste P, Dion S.
    Mol Pharmacol; 1987 Dec 20; 32(6):764-71. PubMed ID: 2826990
    [Abstract] [Full Text] [Related]

  • 32. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
    Patacchini R, Quartara L, Astolfi M, Goso C, Giachetti A, Maggi CA.
    J Pharmacol Exp Ther; 1995 Mar 20; 272(3):1082-7. PubMed ID: 7891319
    [Abstract] [Full Text] [Related]

  • 33. Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung.
    Carstairs JR, Barnes PJ.
    J Pharmacol Exp Ther; 1986 Oct 20; 239(1):249-55. PubMed ID: 3020233
    [Abstract] [Full Text] [Related]

  • 34. Autoradiographic visualization of bradykinin receptors in human and guinea pig lung.
    Mak JC, Barnes PJ.
    Eur J Pharmacol; 1991 Feb 26; 194(1):37-43. PubMed ID: 1647963
    [Abstract] [Full Text] [Related]

  • 35. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM, Qian X, Schiller PW, Szeto HH.
    J Pharmacol Exp Ther; 2003 Dec 26; 307(3):947-54. PubMed ID: 14534366
    [Abstract] [Full Text] [Related]

  • 36. [Discovery and pharmacological properties of selective neurokinin-receptor antagonists, FK224 and FK888].
    Fujii T.
    Nihon Yakurigaku Zasshi; 1995 Sep 26; 106(3):193-204. PubMed ID: 8529964
    [Abstract] [Full Text] [Related]

  • 37. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
    Ciucci A, Palma C, Manzini S, Werge TM.
    Br J Pharmacol; 1998 Sep 26; 125(2):393-401. PubMed ID: 9786514
    [Abstract] [Full Text] [Related]

  • 38. Post soluble binding to the leukotriene D4 receptor from guinea pig lung membranes.
    Mong S, Sarau HM.
    Mol Pharmacol; 1990 Jan 26; 37(1):60-4. PubMed ID: 2153909
    [Abstract] [Full Text] [Related]

  • 39. Isolation and characterization of neurokinin A receptor cDNAs from guinea-pig lung and rabbit pulmonary artery.
    Aharony D, Little J, Thomas C, Powell S, Downey-Jones M, Graham A.
    J Recept Res; 1994 Dec 26; 14(6-8):399-421. PubMed ID: 7877137
    [Abstract] [Full Text] [Related]

  • 40. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ.
    J Pharmacol Exp Ther; 1997 Jul 26; 282(1):181-91. PubMed ID: 9223553
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.